Zachary Bulwa

TL;DR: The role of the nonstenotic, and potentially vulnerable, carotid plaque in ESUS is reviewed, providing a unique opportunity to prospectively determine a subset of patients who may benefit from aggressive medical therapy or endovascular interventions in the prevention of recurrent ESUS.

TL;DR: Most patients with acute stroke and SARS-CoV-2 infection admitted between March 15 to May 15, 2020 to one of the six participating comprehensive stroke centers had clinical evidence of coronavirus infection on admission and preexisting VRFs.

TL;DR: Nonfocal neurological deficits and noncerebrovascular disorders are commonly encountered during in-hospital Stroke Alerts in the inpatient setting while other time-sensitive therapeutic interventions are frequently implemented.

TL;DR: BE-FAST was found to be a very sensitive tool for screening for all in-hospital acute ischemic strokes, including inpatients that were candidates for acute reperfusion therapy and candidates for reperfusions therapy, and among in-patients with acute large vessel occlusion, the sensitivity was 83% and 94%, respectively.

TL;DR: In this article, the authors provide an update on the designation of stroke centers, neurointerventionalist demand, and cost-effectiveness of stroke thrombectomy in the United States.